EPISODE · Nov 24, 2020 · 18 MIN
Vaccine Reality Dose
from The Morning Brief · host The Economic Times
Bharat Biotech failed to halt clinical trials after one person developed serious side-effects during the testing of Covaxin, its indigenously developed Covid-19 vaccine candidate. Dr. Srinath Reddy, President of Public Health Foundation of India, and ET’s Teena Thacker take us through the protocols and challenges of developing a vaccine.See omnystudio.com/listener for privacy information.
Embed this episode
NOW PLAYING
Vaccine Reality Dose
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.